UROMONITOR is transforming bladder cancer monitoring with a highly precise, non-invasive liquid biopsy approach.

Using a urine-based test, it detects highly sensitive and specific biomarkers associated with non-muscle-invasive bladder cancer (NMIBC), delivering accurate and reliable results. This offers an effective solution for recurrence detection in patients under routine surveillance.

With fast and dependable real-time PCR results, UROMONITOR serves as an alternative or complement to current standard-of-care (SOC) methods. In addition to significantly improving patients' quality of life by avoiding invasive procedures, it helps reduce the economic burden of NMIBC follow-up.

Our mission is to provide a simpler, more accessible solution that makes a meaningful impact for both patients and healthcare professionals, raising the standard of care in bladder cancer monitoring.

Uromonitor

This department focuses on managing product development processes and operational efficiency to drive business growth.

Product and Operations

This department is responsible for overseeing sales strategies and managing client relationships across various regions.

Uromonitor

Org chart

Teams

Product and Operations

Sales Management

Offices

Uromonitor

Org chart

Teams

Product and Operations

Sales Management

Offices

Related companies